Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alejandro

Showing results (181-190 of 209) with videos related to

Pageof 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2023
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AMLDavid Levitz, Yogen Saunthararajah, Kateryna Fedorov, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 26, 2011
Chronic kidney disease stage progression in liver transplant recipientsJohn C Lamattina, David P Foley, Joshua D Mezrich, et al.
Blood Cancer Journal|August 21, 2025
Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratificationRajvi Gor, Jeevan Shivakumar, Pallavi Surana, et al.
American Journal of Clinical Pathology|August 30, 2024
Immunophenotypic, genetic, and clinical characterization of adult T-cell leukemia/lymphoma: A single tertiary care center experience in the United StatesUkuemi Edema, John Liu, Maxwell Y Ma, et al.
JMIR Cancer|January 6, 2026
Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot StudyLemchukwu Amaeshi, Lauren Laufer, Kateryna Fedorov, et al.
Diabetes|July 2, 1999
Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154N S Kenyon, L A Fernandez, R Lehmann, et al.
Nature Communications|May 28, 2026
Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastasesMorgan S Fox, Jenny A Jaramillo-Gómez, R Alejandro Marquez-Ortiz, et al.
Leukemia & Lymphoma|May 20, 2022
High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccinationLauren C Shapiro, Astha Thakkar, Radhika Gali, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 19, 2020
Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry DataGurbakhash Kaur, Mateo Mejia Saldarriaga, Nishi Shah, et al.
Stem Cell Investigation|September 4, 2023
Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohortHiba Narvel, Charan Vegivinti, Sindhu Vikash, et al.
Pageof 21

Showing results (181-190 of 209) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2023
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AMLDavid Levitz, Yogen Saunthararajah, Kateryna Fedorov, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 26, 2011
Chronic kidney disease stage progression in liver transplant recipientsJohn C Lamattina, David P Foley, Joshua D Mezrich, et al.
Blood Cancer Journal|August 21, 2025
Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratificationRajvi Gor, Jeevan Shivakumar, Pallavi Surana, et al.
American Journal of Clinical Pathology|August 30, 2024
Immunophenotypic, genetic, and clinical characterization of adult T-cell leukemia/lymphoma: A single tertiary care center experience in the United StatesUkuemi Edema, John Liu, Maxwell Y Ma, et al.
JMIR Cancer|January 6, 2026
Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot StudyLemchukwu Amaeshi, Lauren Laufer, Kateryna Fedorov, et al.
Diabetes|July 2, 1999
Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154N S Kenyon, L A Fernandez, R Lehmann, et al.
Nature Communications|May 28, 2026
Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastasesMorgan S Fox, Jenny A Jaramillo-Gómez, R Alejandro Marquez-Ortiz, et al.
Leukemia & Lymphoma|May 20, 2022
High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccinationLauren C Shapiro, Astha Thakkar, Radhika Gali, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 19, 2020
Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry DataGurbakhash Kaur, Mateo Mejia Saldarriaga, Nishi Shah, et al.
Stem Cell Investigation|September 4, 2023
Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohortHiba Narvel, Charan Vegivinti, Sindhu Vikash, et al.
Pageof 21